When doctors and scientists say that a study was methodologically flawed and unreliable, it’s not because they’re being mean, or trying to maintain the “hegemony,” or to keep the backhanders coming from the pharmaceutical industry; it’s because the study was poorly performed—it costs nothing to blind properly—and simply wasn’t a fair test.
